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Abstract
Acupuncture and moxibustion have been accepted as add-on options for primary dysmenorrhea (PD); however, the clinical
evidence is still inadequate. We searched AMED, CENTRAL, EMBASE, PubMed, Web of Science, CBM, CNKI, VIP, Wangfang
database, ANZCTR, ClinicalTrials.gov, and the WHO ICTRP, from their inception to February 2021. The pooled analysis of
13 RCTs with 675 participants for VAS showed that acupuncture and moxibustion were more effective in managing PD than
the control group with the MD of −1.93 (95% CI [−2.80, −1.06] and −2.67 (95% CI [−4.96, −0.38]). With the CMSS, seven
studies with 487 participants showed that these modalities were more effective than the control group with the MD of −7.58
(95% CI [−10.97, −4.19]) and −3.78 (95% CI [−6.90, −0.66]). The findings indicated that acupuncture and moxibustion could
relieve pain effectively and has fewer adverse events (AEs) in managing PD.
Keywords
acupuncture, moxibustion, primary dysmenorrhea, review, nursing

Introduction
Primary dysmenorrhea (PD), known as period pain, is defined
as painful menstruation in the absence of pelvic pathology
(Kho et al., 2019). The recurrent, crampy, lower abdominal
pain during menstruation are the common characters with
associated symptoms of nausea, vomiting, diarrhea, headaches, dizziness, muscle cramps, back pain, and poor sleep
quality (Kannan & Claydon, 2014; Kho et al., 2019). Globally,
PD affects 50% to 90% of women irrespective of nationality
or age (Committee on Adolescent Health Care, 2018). Half of
these women describe the pain as moderate to severe, restricts
their work and daily activities (Committee on Adolescent
Health Care, 2018), and have adverse events (AEs) on mood
resulting in anxiety and depression; this, in turn, impacts
their experience of pain, pain expression, pain behaviors,
and coping responses (Bernardi et al., 2017; Gagua, 2013).
Despite the importance of this subject, clinical PD management options are still inadequate. At present, nonsteroidal
anti-inflammatory drugs (NSAIDs) are the first-line treatment for PD (Ferries-Rowe et al., 2020; Proctor & Farquhar,
2006). While side effects are commonly reported with
NSAIDs, such as indigestion, headaches, and drowsiness,
the therapeutic superiority of any individual NSAID on PD

management has not been demonstrated (Marjoribanks et al.,
2015); moreover, 18% of women with dysmenorrhea are
unresponsive to such treatment (Oladosu et al., 2018). As
reported, many young women tend to use self-care methods,
but they may not necessarily choose the most effective
options for PD (Armour et al., 2019). Therefore, finding an
effective non-pharmacological method for PD management
has a significant potential value and is urgently needed.
As important modalities of Traditional Chinese Medicine
(TCM), acupuncture and moxibustion are recommended as
safe options with fewer AEs and have been widely used to
alleviate pain (Lee et al., 2010; Shen et al., 2019; Zhao,
2008). Previous publications reported that acupuncture and
moxibustion treatments are effective for PD (Cho & Hwang,
2010; Gou et al., 2016); however, recent studies have
shown that the reporting and methodological quality are
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Table 1. Searching Strategy Examples.
Items searching strategy examples
PubMed
#1 ((“acupuncture” [MeSH Terms] OR “acupuncture therapy” [MeSH Terms] OR Acupuncture [Text Word] OR
Pharmacopuncture OR “Acupuncture Treatment” OR “Acupuncture Treatments” OR (Treatment, Acupuncture)
OR (Therapy, Acupuncture) OR “Pharmacoacupuncture Treatment” OR (Treatment, Pharmacoacupuncture)
OR “Pharmacoacupuncture Therapy” OR (Therapy, Pharmacoacupuncture) OR Acupotomy OR Acupotomies OR
“Acupuncture Point” OR (Point, Acupuncture) OR (Points, Acupuncture) OR Acupoints OR Acupoint OR (Analgesia,
Acupuncture) OR “Acupuncture Anesthesia” OR “Anesthesia, Acupuncture”)
#2 ((“Moxibustion” [MeSH Terms] OR Moxibustion [Text Word] OR “Moxibustion therapy” OR “laser
moxibustion”))
#3 #1 OR #2
#4 (“dysmenorrhea” [MeSH Terms] OR dysmenorrhea [Text Word] OR “Painful period” OR Dysmenorrheas OR
(Pain, Menstrual) OR “Menstrual Pain” OR “Menstrual Pains” OR (Pains, Menstrual) OR (Menstruation, Painful) OR
(Menstruations, Painful) OR “Painful Menstruation” OR “Painful Menstruations”)
#5 #3 AND #4
CNKI database
( ( ( 主题% = 针灸 + 温针灸 + 电针 + 针刺 + 针法 or 题名% = 针灸 + 温针灸 + 电针 + 针刺 + 针法 or title = xls (针灸) + xls
(温针灸) + xls (电针) + xls (针刺) + xls (针法) or subject = xls (针灸) + xls (温针灸) + xls (电针) + xls (针刺) + xls (针法) ) OR
( 主题% = 艾灸 + 灸法 + 电子灸 + 激光灸or 题名% = 艾灸 + 灸法 + 电子灸 + 激光灸 or title = xls (艾灸) + xls (灸法) + xls
(电子灸) + xls (激光灸) or subject = xls (艾灸) + xls (灸法) + xls (电子灸) + xls (激光灸) ) ) AND ( 主题% = 痛经 + 经痛 + 经行腹
痛 + 行经腹痛 or 题名% = 痛经 + 经痛 + 经行腹痛 + 行经腹痛 or title = xls (痛经) + xls (经痛) + xls (经行腹痛) + xls (行经腹痛) or
subject = xls (痛经) + xls (经痛) + xls (经行腹痛) + xls (行经腹痛) ) )；检索范围：总库。

suboptimal, limiting their results’ conviction (Yang et al.,
2020; Zhang et al., 2018). Thus, this review aims to provide
updated knowledge by synthesizing the best available evidence for PD.

Methods
Data Sources and Search Strategy
We searched five English databases and four Chinese databases that including Allied and Complementary Medicine
Database (AMED), Cochrane Central Register of Controlled
Trials (CENTRAL), Excerpta Medica database (EMBASE),
PubMed, and Web of Science; Chinese Biological Medicine
Database (CBM), China National Knowledge Infrastructure
(CNKI), Chinese Technical Periodicals (VIP), and Wangfang
database. To avoid publication bias, we also searched the
Australian New Zealand Clinical Trials Registry (ANZCTR),
ClinicalTrials.gov, and the World Health Organization
International Clinical Trials Registry Platform (WHO ICTRP).
The above searches are limited to English and Chinese from
inception to February 2021. We contacted authors to identify
additional information with missing or incomplete data.
The search strategies were developed through a combination of Mesh terms and keywords: acupuncture, acupuncture
therapy, acupuncture treatment, acupuncture point, moxibustion, moxibustion therapy, moxa, laser moxibustion, dysmenorrhea, primary dysmenorrhea, painful period, algomenorrhea,
and menstrual pain. The search strategy was adapted to different databases demands, and some examples are shown in
Table 1.

Inclusion and Exclusion Criteria
Participants. Women aged 18 to 40 years with a clinically
diagnosed PD were included. Western medicine diagnosis
criteria were based on recurrent, crampy, and lower abdominal pain during menstruation in the absence of pelvic pathology (Kho et al., 2019). The TCM diagnosis was based on
TCM syndrome differentiation, for example, Qi and Blood
stagnation; Cold and Dampness stasis. Animal studies, secondary dysmenorrhea, women aged outside of the 18 to 40
age bracket were excluded.
Intervention(s). All types of acupuncture (manual, electro, or
laser) and or moxibustion (direct, indirect, electronic, or
laser) were included. Wrist-ankle needle, auricular acupuncture, scalp acupuncture, fire needle, acupoint catgut embedding, acupoint injection, and other non-traditional therapies
were excluded.
Comparator. Control treatments included were no treatment,
sham group (sham acupuncture or moxibustion), or usual
care.
Outcomes. (a) The efficacy of acupuncture and or moxibustion for PD measured by validated tools. (b) The treatment
regimen (acupoints formula and intervention dosage). (c)
Safety of acupuncture and moxibustion as measured by any
reported AEs.
Study type. Randomized controlled trials (RCTs) were
included.

Liu et al.

Study Selection and Data Extraction
Two reviewers (WL and CW) screened the titles and abstracts
of all the retrieved studies by removing duplicates and
excluding all irrelevant studies. Only those studies with full
text were retrieved for further screening. WL checked all the
eligible studies, and discussions with CW, XM, and TK
solved any disagreements.
The data extraction was conducted by WL and CW and
validated by KL. The extraction content includes characteristics of included studies (authors, year of publication, and
study setting); participant (age, sample size, and diagnostic
criteria); intervention regime (acupuncture and moxibustion
types, acupoints formula, treatment dosage, and control
group types); outcomes measurement tools used; and AEs.
Where necessary, we contacted authors for further information concerning the exact logistics of the randomization
process.

Quality Assessment and Data Synthesis
All included studies were independently evaluated and crosschecked for methodological quality using the Cochrane risk
of bias tool (Higgins et al., 2011) by two reviewers (WL and
CW), and disagreements were resolved by discussion and
consensus with another reviewer (KL). The evaluation items
included “random allocation,” “allocation concealment,”
“blinding of participants and personnel,” “blinding of outcome assessment,” “complete outcome data,” “selective outcome reporting,” and “other bias.” The items were evaluated
for “high risk,” “unclear risk,” or “low risk.”
The data were summarized using the weighted mean difference (MD) with 95% confidence intervals (CI) for continuous outcomes. The test of statistical homogeneity of
effects across studies was performed using the χ2 distributed Cochrane Q test, with p ≤ .10 indicating significance,
and formally quantified by I2 statistic, with a value less
than 25% indicating low, 25% to 50% indicating moderate,
and greater than 50% indicating high heterogeneity. The
random-effect model was applied to the heterogeneity studies. Causes of heterogeneity were then examined by subgroup analysis and sensitivity analysis. Potential publication
bias was explored by funnel plot, Egger’s (Egger et al.,
2009) test and Begg’s test (Begg & Mazumdar, 1994). All
analyses were conducted using Meta-Analysis Packages in
R (Balduzzi et al., 2019).

Results
Study Selection
The PRISMA flow chart of study selection is shown in
Figure 1. After a vigorous study selection process, 73 studies
were eligible among 9,761 identified studies from 12 electronic databases and clinical trials registry platforms. We
evaluated the quality of these 73 studies according to the
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Cochrane risk of bias assessment. Results showed that 51
studies had a “low risk of bias” in less than five domains,
which was considered low quality and therefore excluded.
Subsequently, 22 studies were finally obtained for analysis
(Figure 2).

Characteristics of the Included Studies
Table 2 summarizes the 22 studies included in this review,
and these studies comprised of 1,634 randomized PD participants, with 4 studies (Sriprasert et al., 2015; Liu et al., 2020;
Wang et al., 2019; Yang et al., 2017) published in English
and 18 studies published in Chinese. The included trials were
mainly conducted in China (n = 21) and Thailand (n = 1).
There were 17 studies (Cai, 2012; Chen, 2013; Han et al.,
2015; Jiang et al., 2020; Li, 2014; Lin, 2020; Liu, 2008; Luo,
2015; Peng, 2019; Tian, 2020; Wang, 2008, 2016; Wang
et al., 2019; Yang et al., 2017; Zhang, 2017, 2019; Zhu,
2015) that measured pain with visual analogue scale (VAS),
with no less than 4 cm as their inclusion criteria, while the
other 5 (Bu et al., 2011; Deng, 2019; Li, 2012; Liu et al.,
2020; Sriprasert et al., 2015) did not report the details of such
inclusion criteria. The average participants age in these RCTs
was 19 to 27 years.
For the intervention group, there were 13 studies on acupuncture (Bu et al., 2011; Cai, 2012; Chen, 2013; Han et al.,
2015; Li, 2014; Liu, 2008; Luo, 2015; Sriprasert et al., 2015;
Tian, 2020; Wang, 2008, 2016; Wang et al., 2019; Zhang,
2017), 5 on moxibustion (Jiang et al., 2020; Liu et al., 2020;
Yang et al., 2017; Zhang, 2019; Zhu, 2015), and 4 on the
combination of both acupuncture and moxibustion (Deng,
2019; Li, 2012; Lin, 2020; Peng, 2019). Besides, there were
15 studies (Chen, 2013; Deng, 2019; Han et al., 2015; Li,
2012, 2014; Lin, 2020; Luo, 2015; Peng, 2019; Sriprasert
et al., 2015; Tian, 2020; Wang, 2016; Wang et al., 2019; Yang
et al., 2017; Zhang, 2017, 2019) with a single intervention
group, and 7 (Bu et al., 2011; Cai, 2012; Jiang et al., 2020;
Liu, 2008; Liu et al., 2020; Wang, 2008; Zhu, 2015) included
two intervention groups. The details of “De Qi”(tingling,
numbness, heaviness, and other feelings) after acupuncture
and or moxibustion applied were reported in 16 included
studies (Bu et al., 2011; Cai, 2012; Chen, 2013; Deng, 2019;
Han et al., 2015; Li, 2014; Lin, 2020; Liu, 2008; Liu et al.,
2020; Luo, 2015; Peng, 2019; Sriprasert et al., 2015; Tian,
2020; Wang, 2008; Yang et al., 2017; Zhang, 2017), but
failed to report in the other 6 (Jiang et al., 2020; Li, 2012;
Wang, 2016; Wang et al., 2019; Zhang, 2019; Zhu, 2015).
For the control group, there were five studies on no-treatment (Bu et al., 2011; Cai, 2012; Liu et al., 2020; Tian, 2020;
Zhu, 2015), seven on sham (Chen, 2013; Han et al., 2015; Li,
2014; Luo, 2015; Wang, 2016; Zhang, 2017, 2019), eight on
oral pills (seven Ibuprofen capsules and one combined contraceptive pill; Deng, 2019; Jiang et al., 2020; Li, 2012; Lin,
2020; Peng, 2019; Sriprasert et al., 2015; Wang et al., 2019;
Yang et al., 2017), and two with two options (no-treatment
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Figure 1. Flowchart of literature selection on randomized controlled trials of acupuncture and or moxibustion for managing PD.

Note. PD = Primary dysmenorrhea; AMED = Allied and Complementary Medicine Database; CENTRAL = Cochrane Central Register of Controlled Trials;
EMBASE = Excerpta Medica Database; ANZCTR = Australian New Zealand Clinical Trials Registry; WHO ICTRP = The World Health Organization
International Clinical Trials Registry Platform; CBM = Chinese Biological Medicine Database; CNKI = China National Knowledge Infrastructure;
VIP = Chinese Technical Periodicals; Wangfang = Wangfang Database.

and sham-group; Liu, 2008; Wang, 2008). The outcomes of
included studies were presented in different ways, including
pain intensity assessment scale, symptom assessment, efficacy index, mental-related factors, and lab tests. There were
18 studies (Chen, 2013; Deng, 2019; Han et al., 2015; Jiang
et al., 2020; Li, 2014; Lin, 2020; Liu, 2008; Liu et al., 2020;
Luo, 2015; Peng, 2019; Tian, 2020; Wang, 2008, 2016; Wang
et al., 2019; Yang et al., 2017; Zhang, 2017, 2019; Zhu,
2015) using the VAS, although three of them were not
included, therefore, failed data synthesis in our meta-analysis due to missing information. Ten studies (Bu et al., 2011;
Chen, 2013; Deng, 2019; Jiang et al., 2020; Liu et al., 2020;
Luo, 2015; Tian, 2020; Wang, 2016; Yang et al., 2017; Zhu,
2015) using the COX menstrual symptom scale (CMSS),

however, two of them were not included in our meta-analysis
due to missing information. Five studies using TCM dysmorphia symptom score (Cai, 2012; Deng, 2019; Li, 2012; Lin,
2020; Peng, 2019), four studies using Self rating Anxiety
Scale (SAS) and Self rating Depression Scale (SDS; Liu
et al., 2020; Tian, 2020; Wang, 2016; Zhu, 2015). Nine studies reported AEs (Lin, 2020; Liu et al., 2020; Luo, 2015;
Peng, 2019; Sriprasert et al., 2015; Tian, 2020; Wang, 2016;
Wang et al., 2019; Zhang, 2017), but these events were mild
and all recovered without taking further actions. One study
reported events without specific description (Zhu, 2015),
four studies suggested these modalities were safe without
any AEs (Deng, 2019; Li, 2012; Yang et al., 2017; Wang,
2008), and eight studies did not report AEs related

Liu et al.
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Figure 2. (a) Risk of bias graph and (b) risk of bias summary.

information (Bu et al., 2011; Cai, 2012; Chen, 2013; Han
et al., 2015; Jiang et al., 2020; Li, 2014; Liu, 2008; Zhang,
2019).

Quality Assessment
A summary of the risks of bias in included studies is presented in Figure 2. Twenty-two studies were at low risk of
selection bias related to the random sequence generation.
Four studies did not describe allocation concealment and
were at unclear risk of this bias (Bu et al., 2011; Chen, 2013;
Jiang et al., 2020; Wang, 2016). However, selection bias did
not appear to be an issue in these trials because of the similar
baseline among groups. Due to the nature of acupuncture
studies, absolute double-blinding was often not possible.
Twenty-two trials were at high risk of bias in this category.
Among these trials, seven trials reported to having an unclear
risk of blinding of outcome assessment (Deng, 2019; Cai,
2012; Li, 2012; Peng, 2019; Sriprasert et al., 2015; Wang,
2008; Zhang, 2019). The complete outcome data and selective reporting were not described clearly for two trials (Luo,
2015; Zhang, 2017), whereas the other two trials were at
unclear risk of such bias (Liu, 2008; Zhu, 2015). However,
the overall risk of bias for all included studies remained low
(Figure 2).

Efficacy of Acupuncture or Moxibustion
VAS. Of the trials that measured pain with the VAS, 13 studies could be pooled for meta-analysis with acupuncture or
moxibustion; however, 2 studies with acupuncture plus moxibustion were excluded due to insufficient studies. In subgroup analyses, groups that received acupuncture or
moxibustion were effectively managed PD compared with
the control group with a MD of −1.93 (95% CI [−2.80,
−1.06]) and −2.67 (95% CI [−4.96, −0.38]), respectively.

There was statistical heterogeneity for PD outcomes on acupuncture group (p <  0.1, I2 = 86%) and moxibustion group
(p < 0.1, I² = 98%). Therefore, we conducted a sensitivity
analysis. Sensitivity analysis was performed by removing the
studies one by one; the result showed that the pooled effect
size was still statistically significant, and the forest plot
direction did not change significantly before and after
removal. Thus, the high heterogeneity might not be caused
by every single study (Figure 3a and b).
CMSS. Of the trials that measured pain with the CMSS,
seven studies could be pooled for meta-analysis with acupuncture or moxibustion; however, one study with acupuncture plus moxibustion were excluded due to the small sample.
In subgroup analyses, groups that received acupuncture or
moxibustion were effectively managed PD compared with
the control group with a MD of −7.58 (95% CI [−10.97,
−4.19]) and −3.78 (95% CI [−6.90, −0.66]), respectively.
There was statistical heterogeneity for PD outcomes on acupuncture group (p < 0.1, I2 = 65%) and moxibustion group
(p <  0.1, I2 = 95%). Therefore, we conducted a sensitivity
analysis. Sensitivity analysis was performed by removing the
studies one by one; the result showed that the pooled effect
size was still statistically significant, and the forest plot
direction did not change significantly before and after
removal. Thus, the high heterogeneity might not be caused
by every single study (Figure 3c and d).

Descriptive Analysis of Other Outcomes
Some included studies could not be subjected to meta-analysis due to the significant variations in acupuncture and moxibustion intervention regimes and outcome measurement
instruments. We have tried to synthesize these results, but not
satisfactory. Thus, this review narratively reported results
from these included trials.
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T:25.0
C:23.8

T:21.7
C:21.9

T:24.1
C:23.9

T:7.5 C:7.0

T:7.6 ± 1.5 C:7.6 ±
1.6

8 ≥ VAS ≥ 4

n = 66
T:33
C:33

n = 233
T1:78
T2:77
C:78

n = 36
T:18
C:18
n = 60
T:30
C:30

n = 60
T:30
C:30

n = 64
T:32
C:32

n = 24
T:12
C:12

n = 152
I:76
C:76

Liu et al.
(2020),
China

Tian
(2020),
China
Deng
(2019),
China

Peng
(2019),
China

Wang
et al.
(2019),
China

Zhang
(2019),
China

Yang et al.
(2017),
China

T:6.4 ± 1.3
C:6.4 ± 1.3

NR

T:6.8 ± 1.7
C:6.6 ± 2.0

NR

T:6.7 ± 1.2
C:6.9 ± 1.1

T:23.0
C:23.1

T:22.6
C:22.5

T:23.2
C:22.1

T1:20.0
T2:20.0
C:20.0

T:24.4
C:24.6

T1:22.7
T2:22.0
C:22.4

Lin (2020),
China

≥4

n = 90
T1:30
T2:30
C:30

Mean age
(year)

Jiang et al.
(2020),
China

Pain score
(VAS: cm)

Sample
size

Author,
country

Moxibustion: Guanyuan (CV4), Shenque
(CV8), Sanyinjiao (SP6; bilateral);
30 minutes × 1 × 7 days for 3 menstrual cycles
(21 sessions)/De Qi (n = 75)

T1: Chinese herbal moxibustion: back
of Dazhui (GV14) to Yaoshu (GV2);
45 minutes × 1 × 3 days for three menstrual
cycles (9 sessions)/NR (n = 30)
T2: Mild moxibustion: Guanyuan (CV4), Zusanli
(ST36); 30 minutes × 1 × 10 days for three
menstrual cycles (30 sessions)/NR (n = 30)
Acupuncture and moxibustion: Shiqizhui
(EX-B8), Dazhui (GV14), Geshu (BL17);
30 minutes × 1 × 7 days for three menstrual
cycles (21 sessions)/De Qi (n = 31)
T1: Moxibustion: treatment before the onset
of menstruation, Sanyinjiao (SP6), Guanyuan
(CV4); 30 minutes × 1 × 6 days for 3 menstrual
cycles (18 sessions)/De Qi (n = 64)
T2: Moxibustion: treatment during the
menstrual period, Sanyinjiao (SP6), Guanyuan
(CV4); 30 minutes × 1 × 6 days for 3 menstrual
cycles (18 sessions)/De Qi (n = 68)
Acupuncture: Sanyinjiao (SP6), Guanyuan (CV4);
30 minutes × 1 × 6 d for 3 menstrual cycles
(18 sessions)/De Qi (n = 18)
Acupuncture and moxibustion: Qihai (CV6),
Guanyuan (CV4), bilateral Xuehai (SP10) and
Taichong (LR3); 30 minutes × 1 × 4 days for 1
menstrual cycle (4 session)/De Qi (n = 30)
Acupuncture and ginger moxibustion: bilateral
Shangliao (BL31), Ciliao (BL32), Zhongliao
(BL33), Xialiao (BL34); 60 minutes × 1 × 6 days
for 3 menstrual cycles (18 sessions)/De Qi
(n = 30)
Acupuncture: Zhibian (BL54), Shuidao (ST28),
Hegu (LI 4), Taichong (LR 3), and Ciliao
(BL32), or Xuehai (SP10), Pishu (BL20),
Zusanli (SP36); 30 minutes × 1 × 5 days for 3
menstrual cycles (15 sessions)/NR (n = 31)
Moxibustion: Guanyuan (CV4);
30 minutes × 1 × 4 days for 3 menstrual cycles
(12 sessions)/NR (n = 12)

Intervention regimen, responses elicited

Sham moxibustion:
professional device, CV4;
30 minutes × 1 × 4 days
for 3 menstrual cycles
(12 sessions; n = 12)
Oral Ibuprofen capsules:
0.6 g × 3 days for 3
menstrual cycles (9
sessions; n = 72)

Oral Ibuprofen capsules:
0.6 g × 5 days for 3
menstrual cycles
(15 sessions; n = 31)

Oral Ibuprofen capsules:
0.6 g × 3 days for 1
menstrual cycle
(3 sessions; n = 28)
Oral Ibuprofen capsules:
0.6 g × 5 days for 3
menstrual cycles
(15 sessions; n = 30)

Waiting-list group: no
treatment (n = 18)

Oral Ibuprofen capsules:
0.6 g × 3 days for 3
menstrual cycles (9
sessions; n = 30)
Waiting-list group: no
treatment (n = 76)

Oral Ibuprofen capsules:
0.6 g × 3 days for three
menstrual cycles (9
sessions; n = 30)

Control regimen

VAS, CMSS, PGF2α,
OT, vWF, β-EP,
PGE2

VAS

VAS, symptom
severity Pain
reduction

VAS, PI, RI, S/D, TCM
dysmenorrhea
symptom score

VAS, CMSS, TCM
dysmenorrhea
symptom score

VAS, CMSS, SAS, SDS,
PSQI, fMRI

VAS, E2, total
effective rate, TCM
dysmenorrhea
symptom score
CMSS, VAS, SAS, SDS

CMSS, VAS, total
effective rate

Outcome

Baseline, during
trial (cycle 1–3),
follow-up (cycle
1–3)

Baseline, during trial
(cycle 3)

Baseline, during trial
(cycle 3), followup (cycle 1)

Baseline, during
trial (cycle 1),
follow-up
(cycle 1)
Baseline, during
trial (cycle 3),
follow-up
(cycle 3)

Baseline, during trial
(cycle 3)

Baseline, during
trial (cycle 3),
follow-up
(cycle 3)
Baseline, during
trial (cycle 1–3),
follow-up
(cycle 1–3)

Baseline, during
trial (cycle 3)

Time of outcome
assessment

Table 2. Characteristic of Included Randomized Controlled Trials on Acupuncture and or Moxibustion for Managing Primary Dysmenorrhea (PD).
Adverse events (AEs)

No AEs

NR

(continued)

T: Mild skin itches (n = 2), mild
blisters (n = 1)
C: Indigestion (n = 1), narcolepsy
(n = 1); all recovered with no
actions taken
T: subcutaneous blooding (n = 7)
C: nausea, anorexia, heartburn, and
bloating (n = 17); all recovered
with no actions taken

Mild blooding and bruises, all
recovered with no actions taken
(n = 2)
No AEs

T1: No details report, recovered
with no actions taken (n = 1)

T: Minor subcutaneous blooding, all
recovered with no actions taken
(n = 4)

NR
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T:21.0
C:21.0

T:24.8
C:23.7

T1:21.1
T2:20.2
C:20.5

T:20.4
C:20.7

T: 6.3 ± 1.6 C:
6.2 ± 1.6

T:62.5 ± 16.1
C:68.3 ± 17.2

T1:67.2 ± 1.3
T2:65.3 ± 11.9 C:
65.3 ± 11.6

T: 5.4 ± 0.9 C:
4.7 ± 0.8

n = 60
T:30
C:30

n = 52
T:27
C:25

n = 12
T:6
C:6

n = 96
T1:32
T2:32
C:32

n = 20
T:10
C:10

n = 60
T:30
C:30

Han et al.
(2015),
China

Sriprasert
et al.
(2015),
Thailand

Luo
(2015),
China

Zhu
(2015),
China

Li (2014),
China

Chen
(2013),
China

≥4
T:19.7
C:19.8

T:24.2
C:26.4

T:22.7
C:23.3

T: 7.3 ± 1.6 C:
7.0 ± 1.6

n = 12
T:6
C:6

Wang
(2016),
China

NR

T:24.8
C:23.6

T: 7.0 ± 1.0 C:
6.8 ± 1.2

n = 16
T:8
C:8

Zhang
(2017),
China

Mean age
(year)

Pain score
(VAS: cm)

Sample
size

Author,
country

Table 2. (continued)

Acupuncture: bilateral Sanyinjiao (SP6) and
Diji (SP8); instant acupuncture (1 session);
30 minutes/De Qi (n = 30)

T1: Moxibustion: treatment before the onset
of menstruation, CV4, SP6 (bilateral);
30 minutes × 1 × 6 days for 3 menstrual cycles
(18 sessions)/ NR (n = 31)
T2: Moxibustion: treatment during the
menstrual period, CV4, SP6 (bilateral);
30 minutes × 1 × 6 days for 3 menstrual cycles
(18 sessions; n = 30)/NR
Acupuncture: Sanyinjiao (SP6; bilateral); instant
acupuncture (1 session), 8 minutes/De Qi
(n = 10)

Acupuncture: Sanyinjiao (SP6; bilateral), instant
acupuncture (1 sessiom), 7 minutes/De qi
(n = 6)

Acupuncture: Qihai (CV6), Zhongqi (CV3),
bilateral Diji (SP8) and Sanyinjiao (SP6);
20 minutes × 1 × 6 days for 3 menstrual cycles
(18 sessions)/De Qi (n = 18)

Acupuncture: Sanyinjiao (SP6; bilateral);
30 minutes × 1 × 1 days for 3 menstrual cycles
(3 sessions)/De Qi (n = 30)

Electroacupuncture: Sanyijiao (SP6; bilateral);
30 minutes × 1 × 7 days for 3 menstrual cycles
(21 sessions)/NR (n = 6)

Acupuncture: Sanyinjiao (SP6); instant
acupuncture (1 session), 7 minutes/De Qi
(n = 8)

Intervention regimen, responses elicited

Sham acupuncture:
professional device (1
session), SP6 (bilateral);
8 minutes (n = 10)
Sham acupuncture:
professional device
(1 session), bilateral
Sanyinjiao (SP6) and
Diji (SP8); instant
acupuncture, 30 minutes
(n = 30)

Sham acupuncture: nonacupoint (bilateral);
instant acupuncture (1
session), 7 minutes (n = 6)
Waiting-list group: no
treatment (n = 30)

Sham acupuncture:
non-acupoint; instant
acupuncture (1 session);
7 minutes (n = 8)
Sham electroacupuncture:
non-acupoint;
30 minutes × 1 × 7 days
for 3 menstrual cycles
(21 sessions; n = 6)
Sham acupuncture:
professional device,
SP6 (bilateral);
30 minutes × 1 × 1 days
for 3 menstrual cycles (3
sessions; n = 30)
Oral combined
contraceptive pill: 70
μg × 1 × 5 days for 3
menstrual cycles (15
sessions; n = 24)

Control regimen

CMSS, VAS

VAS, fMRI

VAS, NRS, CMSS, SAS,
SDS

VAS, CMSS, SAS, SDS,
fMRI

NRS, SF-36,
dysmenorrhea days,
medicine used, pain
reduction

VAS

VAS, CMSS, SAS, SDS,
fMRI

VAS, CMSS, fMRI

Outcome

Baseline, 1, 3, 6, 12,
and 24 hours after
treatment

Baseline, 16 minutes
after treatment

Baseline, during
trial (cycle 1–3),
follow-up (cycle
3)

Baseline, follow-up

Baseline, during trial
(cycle 1–3)

Baseline, during trial
(0.5, 1, 3, 6, and
12 hours for 1–3
cycle)

Baseline, during trial
(cycle 1–3)

Baseline, follow-up

Time of outcome
assessment

NR

NR

T1: n = 2
T2: n = 4
C: n = 1
No details

(continued)

T: Local irritation or minor
blooding (n = 15), headache or
myalgia (n = 4), fever(n = 1)
C: Abnormal vaginal blooding
(n = 9), headache or myalgia
(n = 5), weight gain (n = 3), nausea
or vomiting (n = 2), breast
engorgement (n = 2)
All recovered with no actions taken
Minor blooding and hematoma, all
recovered with no actions taken
(n = 2)

NR

Mild blooding, all recovered with no
actions taken (n = 1)

Mild local blooding and bruises, all
recovered with no actions taken
(n = 3)

Adverse events (AEs)
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T1:19.4
T2:19.9
C:19.7

T1:23.4
T2:22.0
C1:22.7
C2:23.4

T1:23.9
T2:22.0
C1:22.7
C2:23.4

NR

T1:6.1 ± 1.3
T2:5.6 ± 1.0
C1:6.0 ± 1.6
C2:6.5 ± 1.3

T1:5.9 ± 1.2
T2:5.6 ± 1.0
C1:6.0 ± 1.6
C2:6.5 ± 1.3

n = 80
T1:20
T2:20
C:40

n = 41
T1:10
T2:12
C1:9
C2:10

n = 40
T1:9
T2:12
C1:9
C2:10

Bu et al.
(2011),
China

Liu (2008),
China

Wang
(2008),
China

T1: Electroacupuncture: Sanyinjiao (SP6), instant
acupuncture (1 session),10 minutes/De Qi
(n = 9)
T2: Electroacupuncture: Xuanzhong (GB39),
instant acupuncture (1 session),10 minutes/De
Qi (n = 12)

T1: Acupuncture: treatment before the
onset of menstruation, Shiqizhui (EX-B8),
Ciliao (BL32), Diji (SP8), Sanyinjiao (SP6);
30 minutes × 1 × 5 days for 3 menstrual cycles
(15 sessions)/De Qi (n = 95)
T2: Acupuncture: treatment during the
menstrual period, Shiqizhui (EX-B8),
Ciliao (BL32), Diji (SP8), Sanyinjiao (SP6);
30 minutes × 1 × 3 days for 3 menstrual cycles
(9 sessions)/ De Qi (n = 92)
Acupuncture and moxibustion: Guanyuan (CV4),
Qihai (CV6), Zhongqi (CV3), Sanyinjiao (SP6);
30 minutes × 1 × 6 days for 3 menstrual cycles
(18 sessions)/NR (n = 30)
T1: Acupuncture: Shiqizhui (EX-B8);
30 minutes × 1 × 5 days for 3 menstrual cycles
(15 sessions)/De Qi (n = 18)
T2: Acupuncture: Shiqizhui (EX -B 8),
Sanyinjiao (SP6), Diji (SP8), Ciliao (BL32);
30 minutes × 1 × 5 days for 3 menstrual cycles
(15 sessions)/De Qi (n = 17)
T1: Electroacupuncture: Sanyinjiao (SP6), instant
acupuncture (1 session),10 minutes (n = 10)/
De Qi (n = 10)
T2: Electroacupuncture: Xuanzhong (GB39),
instant acupuncture (1 session),10 minutes/De
Qi (n = 12)

Intervention regimen, responses elicited

C1: Shamelectroacupuncture:
non-acupoint; instant
acupuncture (1 session),
10 minutes (n = 9)
C2: Waiting-list group: no
treatment (n = 10)
C1: Shamelectroacupuncture:
non-acupoint, instant
acupuncture (1
session),10 minutes (n = 9)
C2: Waiting-list group: no
treatment (n = 10)

Oral Ibuprofen capsules:
0.6 g × 3 days for 3
menstrual cycles (9
sessions; n = 30)
Waiting-list group: no
treatment (n = 40)

Waiting-list group: no
treatment (n = 99)

Control regimen

VAS, RSS, VRS

VAS, RI, S/D

CMSS

Total effective rate,
TCM dysmenorrhea
symptom score

TCM dysmenorrhea
symptom score

Outcome

Baseline, 10 minutes
after treatment

Baseline, 10 minutes
after treatment

Baseline, during
trial (cycle 1–3),
follow-up (cycle
1–3)

Baseline, during trial
(cycle 1–3)

Baseline, during trial
(cycle 1–3)

Time of outcome
assessment

No AEs

NR

NR

No AEs

NR

Adverse events (AEs)

Note. PD = primary dysmenorrhea; n = number of individuals; NR = no report; T = treatment group; C = control group; VAS = Visual Analog Scale; CMSS = COX Menstrual Symptom Scale; VRS = Verbal Rating Scale;
RSS = Retrospective Symptom Scale; VMSS = Verbal Multidimensional Scoring System; NRS = Numeric Rating Scale; SF-36 = Short Form Health Survey Questionnaire; SAS = Self Rating Anxiety Scale; SDS = Self Rating
Depression Scale; PSQI = Pittsburgh Sleep Quality Index; E2 = serum estradiol; PGE2 = prostaglandin E2; PGF2α = prostaglandin F2α; OT = oxytocin; β-EP = β-endorphin; PI = uterine artery pulsatility index; RI = resistance
index; S/D = peak systolic velocity/diastolic velocity.

T:23.7
C:24.8

NR

n = 60
T:30
C:30

Li (2012),
China

Mean age
(year)
T1:22.5
T2:23.0
C:23.1

n = 300
T1:100
T2:100
C:100

Chen
(2013),
China

Pain score
(VAS: cm)

≥4

Sample
size

Author,
country

Table 2. (continued)

Liu et al.

TCM Dysmenorrhea Symptom Score
Five of the included trials reported TCM dysmenorrhea
symptom score, with three cold congelation and Blood stasis
types (Li, 2012; Lin, 2020; Peng, 2019), one study with Qi
stagnation and Blood stasis type (Deng, 2019), and one is a
combination of them (Cai, 2012). Four studies reported a significant difference between groups in TCM scores after treatment (p < .05; Cai, 2012; Deng, 2019; Li, 2012; Peng, 2019),
but Lin (2020) reported that when compared with the control
group, the difference of treatment group did not reach statistical significance.

Total Effective Rate
The total effective rate was defined as the proportion of participants with symptom severity score reduction after treatment, including four grades of “cure,” “remarkable effect,”

9
“improvement,” and “failure.” Three studies (Jiang et al.,
2020; Li, 2012; Lin, 2020) reported that the total effective
rate in the treatment group was significantly higher than the
control group (p < .05).

SAS and SDS
Four studies used the SAS and SDS at the same time (Liu
et al., 2020; Tian, 2020; Wang, 2016; Zhu, 2015). Only one
of them showed a significant difference between-group after
treatment (p < .01; Zhu, 2015), suggesting that acupuncture
plays an important role in emotion regulation. Conversely,
three studies showed that there was no significant difference between the intervention and control group (p > .05;
Liu et al., 2020; Tian, 2020; Wang, 2016), meaning it may
not affect improving the anxiety and depression of PD
participants.

Figure 3. (continued)
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Figure 3. (a) Forest plots of comparison: effect of treatments versus controls on VAS, two treatment groups were grouped separately
for relevant subgroup analysis, (b) sensitivity analysis: effect of treatments versus controls on VAS, every study was omitted separately
for MD changes, (c) forest plots of comparison: effect of treatments versus controls on CMSS, two treatment groups were grouped
separately for relevant subgroup analysis, and (d) sensitivity analysis: effect of treatments versus controls on CMSS, every study was
omitted separately for MD changes.

Treatment Regimen
All the 22 RCTs reported the specifically applied acupoints
in their treatment. The six most common used acupoints for
managing PD were Sanyinjiao (SP6), Guanyuan (CV4),
Ciliao (BL32), Diji (SP8), Qihai (CV6), and Dazhui (GV14).
Results also revealed that most of the acupoints used in the
included trials were located on the back (e.g., Geshu (BL17),
and Yaoshu (GV2)), with some being located at the abdomen
(e.g., Guanyuan (CV4), Qihai (CV6)), and Zhongji (CV3)
and limbs (e.g., Sanyinjiao (SP6), Diji (SP8), and Zusanli
(ST36)).
In this review, 13 studies (Bu et al., 2011; Cai, 2012;
Deng, 2019; Jiang et al., 2020; Li, 2012; Lin, 2020; Liu et al.,
2020; Peng, 2019; Tian, 2020; Wang, 2016; Wang et al.,
2019; Yang et al., 2017; Zhu, 2015) reported that interventions were used once a day for managing PD, and the most
common treatment frequencies were six times per week
(n = 7), seven times per week (n =4), and five times per week
(n = 4), which were consistent with the frequency of once a
day above. Moreover, the most common duration of interventions was 30 minutes for each time, and studies also
involved 20, 45, and 60 minutes. In addition, six studies (Bu
et al., 2011; Cai, 2012; Chen, 2013; Li, 2012; Liu, 2008;
Wang, 2008) reported that instant acupuncture and or moxibustion was used to observe the immediate analgesic effect.
Nearly 70% of participants in this review received three continuous menstrual cycles treatment for their intervention
doses.

Adverse Events (AEs)
AEs were mentioned in 14 trials (Deng, 2019; Li, 2012; Lin,
2020; Liu et al., 2020; Luo, 2015; Peng, 2019; Sriprasert
et al., 2015; Tian, 2020; Wang, 2008, 2016; Wang et al.,
2019; Yang et al., 2017; Zhang, 2017; Zhu, 2015). Among
which, four studies reported acupuncture was safe with no

AEs during the trials (Deng, 2019; Li, 2012; Wang, 2008;
Yang et al., 2017), one study reported AEs without specific
description (Zhu, 2015), nine studies reported specific AEs
including local and minor irritation, bleeding, hematoma,
bruises, blisters, and these reactions were mild and all recovered that did not affect the participants or the trial (Lin, 2020;
Liu et al., 2020; Luo, 2015; Peng, 2019; Sriprasert et al.,
2015; Tian, 2020; Wang, 2016; Wang et al., 2019; Zhang,
2017). Conversely, eight studies failed to report any AEs (Bu
et al., 2011; Cai, 2012; Chen, 2013; Han et al., 2015; Jiang
et al., 2020; Li, 2014; Liu, 2008; Zhang, 2019).

Analysis of Publication Bias
Funnel plot analysis showed that there were no significant
publication biases for most analyses. Both Begg’s and
Egger’s test results further supported the result of funnel plot
analysis (p > .05).

Discussion
Meta-Analysis of Clinical Effect
Our meta-analysis revealed that acupuncture can significantly reduce the VAS, CMSS, and TCM symptom scores of
PD participants. The total effect rates of the acupuncture
group were significantly higher than the control group.
Therefore, acupuncture could be viewed as an effective
option for PD, which was consistent with the other report
(Cho & Hwang, 2010). Moxibustion is a traditional therapeutic remedy that has been used to treat and prevent disease
for more than thousands. Our review suggested that moxibustion can improve the pain symptoms of the participants,
which were consistent with a previous study (Gou et al.,
2016). Thus, current results showed that acupuncture and
moxibustion could be used as complementary or alternative
therapies for managing PD.

Liu et al.
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The result showed an association between acupuncture or
moxibustion and reduced pain intensity, with a moderate
level of certainty. However, as most studies used a subjective, self-reported index of treatment effects as the outcome
measure, this resulted in the inaccurate pain assessment (Salé
et al., 2010). Anxiety and depression might have a bidirectional association with dysmenorrhea. Experiencing monthly
repeated menstrual pain might increase the risk of anxiety
and depression, and psychological disorders exacerbate the
severity of menstrual pain (Patel et al., 2006). Only four
studies reported anxiety and depression as outcomes in this
review, and there was no evidence that acupuncture and
moxibustion improved anxiety and depression when managing PD. Therefore, more evidence is required on the associations between PD and mental health to inform holistic health.
In the meta-analysis of VAS and CMSS, the high heterogeneity is evident. One major challenge might be the subjective nature of the symptom presentations and the small
sample size. Furthermore, the included studies used different interventions, including acupuncture, electroacupuncture, Chinese herbal moxibustion, and mild moxibustion.
The control group included the waiting-list, sham group,
Ibuprofen, and combined contractual pill. This might result
in high heterogeneity and affect the level of the review.
From a clinical perspective, available evidence suggests acupuncture or moxibustion could be a component of pain management. Nevertheless, high heterogeneity in the results
suggests that the outcomes of these therapies may be varied.
Therefore, we performed subgroup analysis and sensitivity
analysis on the included studies, although the results were
not significantly different.

conditions, environment, and even the patient’s goals. Thus,
there should be an ongoing discussion on referral more individual treatment protocols that meet requirements for clinical trials.

Evidence of the Treatment Regimen

The strengths of this review are as follows: (1) unlike other
reviews, this review did not include “RCT” as the search
restriction and performed an inclusive search in major databases from their inception, and integrated more comprehensive information; (2) this review conducted the quality
assessment with strict criteria to improve the overall quality
of included studies, providing new evidence and opening
new horizons for systematic review; (3) there was no publication bias in this review, which further improved the quality
of evidence; (4) we added the topic of safety in the use of
acupuncture and moxibustion, which is proven to be poorly
reported in the existing literature.
This meta-analysis has several limitations: (1) this review
was limited to Chinese and English research, leading to the
possibility of selection bias; (2) in the generation of random
sequence, some literature only mentioned the word “random,” but did not specify the random method, which might
increase the risk of bias and reduce the quality of research;
(3) many results could not be meta-analyzed due to the significant variations in treatment modalities and outcome measurement instruments; (4) some possible reasons for high
heterogeneity: small sample size, different syndrome types
of PD, nonblinding of participants and practitioners; we tried

This review showed a detailed treatment regimen, including
acupoints formula and intervention dosage, might provide a
reference for managing PD in clinical practice. We found a
set of frequently used points for PD: Sanyinjiao (SP6),
Guanyuan (CV4), Ciliao (BL32), Diji (SP8), Qihai (CV6),
and Dazhui (GV14), and this result coincided with the previous report (Hwang et al., 2020). These acupoints formula
revealed that both local and distal acupoints were used to
treat menstrual pain in clinical trials, suggesting that regional
points are considered the basic rule of point selection based
on the meridian system, and as well as points remote from
the disease site also been chosen by the traditional acupuncture practitioners along the described meridian (Lee et al.,
2013). A report preliminarily summarized frequently-used
acupoints for pain relief and found that needle retention time
was mostly 30 minutes (Liang et al., 2020). This idea was
consistent with our review, more than half of the studies
used a frequency of 30 minutes per time. Moreover, most
participants received repeated once-daily treatment for three
continuous menstrual cycles. However, the treatment regimen is a variable associated with specific musculoskeletal

Summary of the Safety
Few AEs from the acupuncture or moxibustion groups were
reported, which was in line with several previous reviews
(Wang et al., 2019; Chan et al., 2017; Tan et al., 2014; Xu
et al., 2013, 2014). Local and minor irritation, bleeding,
hematoma, bruises, and blisters were the most common AEs
identified in our review across all modalities (manual acupuncture, electroacupuncture, Chinese herbal moxibustion,
and mild moxibustion), all were mild, and all recovered with
no actions taken. Serious side effects were not reported.
However, there is no absolutely safe treatment in the world;
acupuncture and moxibustion remain associated with AEs
and related to some serious risks in certain circumstances.
The position, acupoints, duration, depth and angle of acupuncture, the distance between moxa and skin, proficiency of
practitioners, patient’s conditions, and even the treatment
environment can affect the safety of acupuncture moxibustion. The exact causes of most of these cannot be determined.
Issues should be addressed in further experimental studies.
In general, acupuncture is safe in the hands of competent
practitioners (Vincent, 2001). Adequate supervision and professional training can even further minimize risks during the
trials.

Strengths and Limitations
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to reduce the heterogeneity by synthesizing the data separately depending on the characteristics of the interventions
and controls, and subgroup analysis, but the unresolved heterogeneity still existed. All those results mentioned above
should therefore be interpreted with caution. More rigorous
trials are needed to identify the association of acupuncture
and or moxibustion with PD and integrate such evidence into
clinical care to improve health outcomes.

Conclusions
Based on available evidence, acupuncture and or moxibustion may be associated with significant reductions in PD
by the appropriate treatment regimen. Generally, acupuncture and moxibustion are safe modalities and serious AEs
after treatment are uncommon when supported with wellestablished guidelines, practiced among licensed, qualified
practitioners.
Acknowledgments
We would like to express our sincere appreciation to the authors
who performed all eligible studies included in the present study.

Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article: This
work was supported by the project on Edith Cowan University and
Industry Collaboration Scholarship (G1004906).

Protocol and Registration
The protocol of this review has been registered with PROSPERO
(https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42021234450).

ORCID iDs
Weiting Liu
https://orcid.org/0000-0001-6936-8872
Khui Hung Lee
https://orcid.org/0000-0001-5906-4664

References
Armour, M., Parry, K., Al-Dabbas, M. A., Curry, C., Holmes,
K., MacMillan, F., Ferfolja, T., & Smith, C. A. (2019). Selfcare strategies and sources of knowledge on menstruation in
12,526 young women with dysmenorrhea: A systematic review
and meta-analysis. PLoS One, 14(7), e0220103. https://doi.
org/10.1371/journal.pone.0220103
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019). How to perform a meta-analysis with r: A practical tutorial. EvidenceBased Mental Health, 22(4), 153–160. https://doi.org/10.1136/
ebmental-2019

Clinical Nursing Research 00(0)
Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of
a rank correlation test for publication bias. Biometrics, 50(4),
1088–1101
Bernardi, M., Lazzeri, L., Perelli, F., Reis, F. M., & Petraglia, F.
(2017). Dysmenorrhea and related disorders. F1000Research,
6(F100.0 Faculty Rev), 1645. https://doi.org/10.12688/f1000
research.11682
Bu, Y. Q., Hou, W. J., Li, Y. M., Zhang, B., Cong, Q., Wang, J., &
Chen, S. (2011). Observation on the effect of pre acupuncture
at single point and multiple points on primary dysmenorrhea.
New Chinese Medicine, 4, 99–101. https://doi.org/10.13457/j.
cnki.jncm.2011.04.032
Cai, P. Y. (2012). The effect of acupuncture group points on TCM
syndrome score of patients with primary dysmenorrhea at different intervention times. Shandong University of Traditional
Chinese Medicine.
Chan, M. W. C., Wu, X. Y., Wu, J. C. Y., Wong, S. Y. S., & Chung,
V. C. H. (2017). Safety of acupuncture: Overview of systematic
reviews. Scientific Reports, 7(1), 3369. https://doi.org/10.1038/
s41598-017-03272-0
Chen, X. Y. (2013). Evaluation of analgesic effect of acupuncture
on primary dysmenorrhea and exploration of its brain function mechanism. Henan University of Traditional Chinese
Medicine.
Cho, S. -H., & Hwang, E. -W. (2010). Acupuncture for primary
dysmenorrhea: A systematic review. BJOG, 117(5), 509–521.
https://doi.org/10.1111/j.1471-0528.2010.02489.x
Committee on Adolescent Health Care. (2018). ACOG Committee
Opinion No. 760: Dysmenorrhea and endometriosis in the
adolescent. Obstetrics and Gynecology, 132(6), e249–e258.
https://doi.org/10.1097/AOG.0000000000002978
Deng, J. H. (2019). Therapeutic effect of warm acupuncture on
primary dysmenorrhea of qi stagnation and blood stasis type.
Guangzhou University of Traditional Chinese Medicine.
Egger, M., Davey Smith, G., Schneider, M., & Minder, C.
(1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634. https://doi.org/10.1136/
bmj.315.7109.629
Ferries-Rowe, E., Corey, E., & Archer, J. S. (2020). Primary dysmenorrhea: Diagnosis and therapy. Obstetrics Gynecology, 136(5),
1047–1058. https://doi.org/10.1097/AOG.0000000000004096
Ford, I., & Norrie, J. (2016). Pragmatic trials. New England
Journal of Medicine, 375(5), 454–463. https://doi.org/10.1056/
NEJMra1510059
Gagua, T., Tkeshelashvili, B., Gagua, D., & McHedlishvili, N.
(2013). Assessment of anxiety and depression in adolescents
with primary dysmenorrhea: A case-control study. Journal of
Pediatric and Adolescent Gynecology, 26(6), 350–354. https://
doi.org/10.1016/j.jpag.2013.06.018
Gou, C. Q., Gao, J., Wu, C. X., Bai, D. X., Mou, H. Y., Hou,
X. L., & Zhao, X. (2016). Moxibustion for primary dysmenorrhea at different interventional times: A systematic
review and meta-analysis. Evidence-Based Complementary
and Alternative Medicine, 2016, 6706901. https://doi.org
/10.1155/2016/6706901
Han, Y., Zhou, Y. L., Guo, X., Liu, Y., Li, H., & Chen, X. (2015).
Clinical observation on analgesic effect of true and false
acupuncture at Sanyinjiao point on primary dysmenorrhea.

Liu et al.
Chinese Journal of Acupuncture, 35(4), 318–322. https://doi.
org/10.13703/j.0255-2930.2015.04.002
Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher,
D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., &
Sterne, J. A. (2011). The Cochrane Collaboration’s tool for
assessing risk of bias in randomized trials. BMJ, 343, d5928.
https://doi.org/10.1136/bmj.d5928
Hwang, Y. -C., Lee, I. S., Ryu, Y., Lee, M. S., & Chae, Y. (2020).
Exploring traditional acupuncture point selection patterns for
pain control: Data mining of randomised controlled clinical
trials. Acupuncture in Medicine. Advance online publication.
https://doi.org/10.1177/0964528420926173
Jiang, M., Ding, L., Li, Q., Hu, X., & Deng, C. (2020). A control study on the effect of long snake moxibustion on primary
dysmenorrhea of cold coagulation and blood stasis type.
Jiangxi Medical Journal, 55(5), 568–570+611. https://doi.
org/10.3969/j.issn.1006-2238.2020.05.025
Kannan, P., & Claydon, L. S. (2014). Some physiotherapy treatments may relieve menstrual pain in women with primary dysmenorrhea: A systematic review. Journal of Physiotherapy,
60(1), 13–21. https://doi.org/10.1016/j.jphys.2013.12.003
Kho, K. A., & Shields, J. K. (2020). Diagnosis and management
of primary dysmenorrhea. JAMA, 323(3), 268–269. https://doi.
org/10.1001/JAMA.2019.16921
Lee, I. S, Lee, S. H., Kim, S. Y., Lee, H., Park, H. J., & Chae, Y.
(2013). Visualization of the meridian system based on biomedical information about acupuncture treatment. Evidence-Based
Complementary and Alternative Medicine, 2013, 872142.
https://doi.org/10.1155/2013/872142
Lee, M. S., Choi, T. Y., Kang, J. W., Lee, B. J., & Ernst, E.
(2010). Moxibustion for treating pain: A systematic review.
The American Journal of Chinese Medicine, 38(5), 829–838.
https://doi.org/10.1142/S0192415X10008275
Liang, Q., Zhang, K., Wang, S. M., Xu, X., Liu, Y., Cui, S., &
Liu, L. (2020). Acupuncture for cancer pain: An adjuvant
therapy for cancer pain relief. The American Journal of
Chinese Medicine, 48, 1769–1786. https://doi.org/10.1142/
S0192415X20500883
Lin, G. H. (2020). Clinical observation on treating primary dysmenorrhea of cold coagulation and blood stasis type with
warm acupuncture and moxibustion at 17 vertebrae. Fujian
University of Traditional Chinese medicine.
Li, H. (2014). Study on brain function mechanism of acupuncture
at Sanyinjiao for primary dysmenorrhea. Henan University of
Traditional Chinese Medicine.
Liu, L. Y., Li, X. J., Wei, W., Guo, X. L., Zhu, L. H., Gao, F. F.,
Liang, F. R., Yu, S. Y., & Yang, J. (2020). Moxibustion for
patients with primary dysmenorrhea at different intervention
time points: A randomized controlled trial. Journal of Pain
Research, 13, 2653–2662. https://doi.org/10.2147/JPR.S270698
Liu, X. L. (2008). Effect of acupuncture at Sanyinjiao (SP6) on
uterine artery blood flow in patients with primary dysmenorrhea. Shandong University of Traditional Chinese Medicine.
Li, X. J. (2012). Observation of the clinical effect of warm acupuncture on the treatment of primary dysmenorrhea of cold coagulation and stasis type. Guangzhou University of Traditional
Chinese Medicine.
Luo, X. (2015). Study on the mechanism of immediate effect of acupuncture on primary dysmenorrhea based on fMRI. Chengdu
University of Traditional Chinese Medicine.

13
Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M.
(2015). Nonsteroidal anti-inflammatory drugs for dysmenorrhea. The Cochrane Database of Systematic Reviews, 2015(7),
CD001751. https://doi.org/10.1002/14651858.CD001751.pub3
Oladosu, F. A., Tu, F. F., & Hellman, K. M. (2018). Nonsteroidal
anti-inflammatory drug resistance in dysmenorrhea:
Epidemiology, causes, and treatment. American Journal of
Obstetrics and Gynecology, 218(4), 390–400.
Patel, V., Tanksale, V., Sahasrabhojanee, M., Gupte, S., &
Nevrekar, P. (2006). The burden and determinants of dysmenorrhoea: A population-based survey of 2262 women in Goa,
India. BJOG, 113(4), 453–463. https://doi.org/10.1111/j.14710528.2006.00874.x
Peng, Y. X. (2019). Clinical study on acupuncture combined with
ginger partitioned moxibustion at Baliao point in treating dysmenorrhea of cold coagulation and blood stasis type. Guangxi
University of Traditional Chinese Medicine.
Proctor, M., & Farquhar, C. (2006). Diagnosis and management
of dysmenorrhea. BMJ, 332(7550), 1134–1138. https://doi.
org/10.1136/bmj.332.7550.1134
Salé, H., Hedman, L., & Isberg, A. (2010). Accuracy of patients’
recall of temporomandibular joint pain and dysfunction after
experiencing whiplash trauma: A prospective study. Journal of
the American Dental Association, 141(7), 879–886. https://doi.
org/10.14219/jada.archive.2010.0287
Sriprasert, I., Suerungruang, S., Athilarp, P., Matanasarawoot,
A., & Teekachunhatean, S. (2015). Efficacy of acupuncture
versus combined oral contraceptive pill in treatment of moderate-to-severe dysmenorrhea: A randomized controlled trial.
Evidence-Based Complementray and Alternative Medicine,
2015, 735690. https://doi.org/10.1155/2015/735690
Shen, B., Sun, Q., Chen, H., Li, Y., Du, X., Li, H., & Xu, G. Y.
(2019). Effects of moxibustion on pain behaviors in patients
with rheumatoid arthritis: A meta-analysis. Medicine
(Baltimore), 98(30), e16413. https://doi.org/10.1097/MD.0000
000000016413
Tan, J. Y., Molassiotis, A., Wang, T., & Suen, L. K. (2014).
Adverse events of auricular therapy: A systematic review.
Evidence-Based Complementary and Alternative Medicine,
2014, 506758. https://doi.org/10.1155/2014/506758
Tian, J. (2020). Study on the effect of acupuncture on brain functional connectivity network of PAG in patients with primary
dysmenorrhea based on resting state fMRI. Chengdu University
of Traditional Chinese Medicine.
Vincent, C. (2001). The safety of acupuncture. BMJ, 323(7311),
467–468. https://doi.org/10.1136/bmj.323.7311.467
Wang, C. C., Tan, J. Y., & Williams, A. (2019). Safety and side
effects of acupuncture therapy in Australia: A systematic
review. European Journal of Integrative Medicine, 27, 81–89.
https://doi.org/10.1016/j.eujim.2019.03.004
Wang, D. (2008). Effect of acupuncture at Sanyinjiao (SP6) on dysmenorrhea accompanying symptoms in patients with primary
dysmenorrhea. Shandong University of Traditional Chinese
Medicine.
Wang, H. J., Cao, Y., Jin, X., Yan, M., Wang, J., Li, R., & Ji, L.
(2019). Effect of an acupuncture technique of penetrating
through Zhibian (BL54) to Shuidao (ST28) with long needle
for pain relief in patients with primary dysmenorrhea: A randomized controlled trial. Pain Research & Management, 2019,
7978180. https://doi.org/10.1155/2019/7978180

14
Wang, Y. X. (2016). The central mechanism of acupuncture treatment of primary dysmenorrhea based on RS fMRI technology.
Chengdu University of Traditional Chinese medicine.
Xu, J., Deng, H. Y., & Shen, X. Y. (2014). Safety of moxibustion: A systematic review of case reports. Evidence-Based
Complementary and Alternative Medicine, 2014, 783704.
https://doi.org/10.1155/2014/783704
Xu, S. F., Wang, L. Z., Cooper, E., Zhang, M., Manheimer, E.,
Berman, B., Shen, X., & Lao, L. (2013). Adverse events of
acupuncture: A systematic review of case reports. EvidenceBased Complementary and Alternative Medicine, 2013,
581203. https://doi.org/10.1155/2013/581203
Yang, J., Xiong, J., Yuan, T., Wang, X., Jiang, Y., Zhou, X., Liao,
K., & Xu, L. (2020). Effectiveness and safety of acupuncture
and moxibustion for primary dysmenorrhea: An overview
of systematic reviews and meta-analyses. Evidence-Based
Complementary and Alternative Medicine, 2020, 8306165.
https://doi.org/10.1155/2020/8306165
Yang, M., Chen, X., Bo, L., Lao, L., Chen, J., Yu, S., Yu, Z., Tang,
H., Yi, L., Wu, X., Yang, J., & Liang, F. (2017). Moxibustion
for pain relief in patients with primary dysmenorrhea: A randomized controlled trial. PLoS One, 12(2), e0170952. https://
doi.org/10.1371/journal.pone.0170952
Zhang, B. Y. (2019). Study on the influence mechanism of moxibustion at Guanyuan point on brain function of primary dysmenorrhea based on ASL fMRI technology. Beijing University of
Traditional Chinese Medicine.
Zhang, F. R., Sun, M. S., Han, S. S., Shen, X. Y., Luo, Y., Zhong,
D., Zhou, X., Liang, F., & Jin, R. (2018). Acupuncture for

Clinical Nursing Research 00(0)
primary dysmenorrhea: An overview of systematic reviews.
Evidence-Based Complementary and Alternative Medicine,
2018, 8791538. https://doi.org/10.1155/2018/8791538
Zhang, Q. (2017). Effect of acupuncture at Sanyinjiao on local consistency of resting state brain function in patients with primary
dysmenorrhea. Chengdu University of Traditional Chinese
Medicine.
Zhao, Z. Q. (2008). Neural mechanism underlying acupuncture
analgesia. Progress in Neurobiology, 85(4), 355–375. https://
doi.org/10.1016/j.pneurobio.2008.05.004
Zhu, L. H. (2015). Randomized controlled study of Moxibustion in
the treatment of primary dysmenorrhea. Chengdu University
of Traditional Chinese Medicine.

Author Biographies
Weiting Liu, Master of Medicine (MM); is a PhD student at Edith
Cowan University; weitingl@our.ecu.edu.au.
Carol Chunfeng Wang, RN, PhD; is a lecturer at Edith Cowan
University; c.wang@ecu.edu.au.
Khui Hung Lee, PhD; is a sessional academic at Edith Cowan
University; khuihung.lee@ecu.edu.au.
Xiaopeng Ma, PhD; is a professor at Shanghai Research Institute
of Acupuncture and Meridian; pengpengma@163.com.
Timothy Leen Kang, MD; is a clinical expert at Institute of
Chinese Acuology; kangtl@hotmail.com.

